Early Access — free while we kick the tires
EdgarHawk

Daniel Maclachlan

Chief Financial Officer

Officer

Latest: Red Violet, Inc. CFO selling · June 2026

2 filings analyzed · 1 company · Latest 2026-06-01

Never miss a filing from Daniel Maclachlan

Watch this insider and we'll alert you the moment they file — at any company.

Companies

Company Buys Sells Direction
Red Violet, Inc. RDVT 0 2 Net selling

Activity

June 2026
2026-06-01 Red Violet, Inc. RDVT
high
Sell
12,000 shares
$689,160
Significance 7/10

CFO Daniel Maclachlan sold 12,000 shares at $57.43 avg; stock up 49.6% in 30d, near 52-week high ($64.14). All 5 prior RDVT sales were well-timed (90d negative returns).

Daniel Maclachlan, CFO of Red Violet, executed 2 separate sales totaling 12,000 shares for $689,160.00 on 2026-06-01 at a blended average price of $57.43, reducing his holdings by 3.2% to 358,902 shares. The current price of $59.30 is -7.6% from the 52-week high of $64.14, though the stock has rallied +49.6% over the prior 30 days. Notably, Maclachlan's prior 5 trades at RDVT were all well-timed at the 90-day mark, each showing negative 90-day returns ranging from -27.2% to -28.6%, suggesting a consistent pattern of selling before declines. His cross-ticker track record shows 7 prior sells with an average 90-day return of -28.5% and a 100.00% well-timed rate, further underscoring a demonstrated ability to exit before downturns. Investors should monitor whether this sale—coming after a +49.6% rally and near the 52-week high—represents another correctly-timed exit or a departure from his historical pattern.

November 2025
2025-11-13 Red Violet, Inc. RDVT
medium
Sell
15,000 shares
$867,943
Significance 5/10

CFO MacLachlan Daniel sold 15,000 shares (15.0K) at $57.86 avg on Nov 10–13, raising $867.9K; retains 358.2K shares.

MacLachlan Daniel, Chief Financial Officer of Red Violet, executed 7 separate sales totaling 15,000 shares for $867,942.57 over four trading days (Nov 10–13, 2025), at a blended average price of $57.86. This represents a 4.0% reduction of his pre-transaction holdings, leaving him with 358,163 shares. The stock has risen 8.9% over the prior 30 days and 31.9% over 90 days, trading at $57.51 currently and within 3.2% of its 52-week high of $59.42. The company's fundamentals show strong revenue growth (+24.9% year-over-year) and profitability ($4.2M net income on $23.1M quarterly revenue), though the P/E of 71.89 reflects a elevated valuation multiple. The CFO's partial reduction in share count during a strong price run and amid rich valuation metrics merits monitoring, particularly given the absence of disclosed trading plan information in this filing.

Related insiders